Indegene Ltd (INEG)

Currency in INR
480.70
+1.45(+0.30%)
Closed·
INEG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
475.95484.00
52 wk Range
455.60640.10
Key Statistics
Bid/Ask
478.75 / 480.70
Prev. Close
480.7
Open
480.45
Day's Range
475.95-484
52 wk Range
455.6-640.1
Volume
244.55K
Average Volume (3m)
231.8K
1-Year Change
-20.957%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INEG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
605.86
Upside
+26.04%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Indegene Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Indegene Company Profile

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Compare INEG to Peers and Sector

Metrics to compare
INEG
Peers
Sector
Relationship
P/E Ratio
26.3x29.6x−0.5x
PEG Ratio
2.290.740.00
Price/Book
4.0x4.5x2.6x
Price / LTM Sales
3.5x2.7x3.3x
Upside (Analyst Target)
24.8%20.9%46.2%
Fair Value Upside
Unlock15.8%6.6%Unlock

Analyst Ratings

4 Buy
3 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 605.86
(+26.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold550.00+14.42%650.00Maintain02/02/2026
Nomura/Instinet
Hold550.00+14.42%570.00Maintain02/02/2026
Nomura/Instinet
Hold570.00+18.58%560.00Maintain02/01/2026
Citi
Sell510.00+6.10%525.00Maintain02/01/2026
Nomura/Instinet
Hold560.00+16.50%530.00Maintain28/11/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 18.21%
Dividend Yield
0.42%
Industry Median 0.99%
Annualised payout
2.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jan 29, 2026
EPS / Forecast
4.30 / 5.55
Revenue / Forecast
9.42B / 9.39B
EPS Revisions
Last 90 days

People Also Watch

887.80
SIGT
+0.63%
444.10
DELH
-0.94%
3,616.10
KAYN
-4.32%

FAQ

What Is the Indegene (INEG) Share Price Today?

The live Indegene share price today is 480.70

What Stock Exchange Does Indegene (INEG) Trade On?

Indegene is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Indegene?

The stock symbol (also called a 'ticker') for Indegene is "INEG."

Does Indegene Pay Dividends? What’s The Current INEG Dividend Yield?

Yes, INEG Pays Dividends to its Shareholders. The current Indegene dividend yield is 0.42%.

What Is the Current Indegene Market Cap?

As of today, Indegene market capitalisation is 115.37B.

What Is Indegene's (INEG) Earnings Per Share (TTM)?

The Indegene EPS is currently 18.21 (Trailing Twelve Months).

When Is the Next Indegene Earnings Date?

Indegene's next earnings report will be released on 30 Jan 2026.

Is INEG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Indegene moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Indegene Stock Split?

Indegene has split 0 times. (See the INEG stock split history page for full effective split date and price information.)

How Many Employees Does Indegene Have?

Indegene has 4158 employees.

What is the current trading status of Indegene (INEG)?

As of 06 Feb 2026, Indegene (INEG) is trading at a price of 480.70, with a previous close of 480.70. The stock has fluctuated within a day range of 475.95 to 484.00, while its 52-week range spans from 455.60 to 640.10.

What Is Indegene (INEG) Price Target According to Analysts?

The average 12-month price target for Indegene is INR605.86, with a high estimate of INR690 and a low estimate of INR550. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +26.04% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.